Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 12;10(7):297.
doi: 10.3390/jcdd10070297.

Assessment and Therapeutic Modulation of Heart Rate Variability: Potential Implications in Patients with COVID-19

Affiliations
Review

Assessment and Therapeutic Modulation of Heart Rate Variability: Potential Implications in Patients with COVID-19

Luiz Schnekenberg et al. J Cardiovasc Dev Dis. .

Abstract

Cardiac damage has been attributed to SARS-CoV-2-related pathology contributing to increased risk of vascular events. Heart rate variability (HRV) is a parameter of functional neurocardiac integrity with low HRV constituting an independent predictor of cardiovascular mortality. Whether structural cardiac damage translates into neurocardiac dysfunction in patients infected with SARS-CoV-2 remains poorly understood. Hypothesized mechanisms of possible neurocardiac dysfunction in COVID-19 comprise direct systemic neuroinvasion of autonomic control centers, ascending virus propagation along cranial nerves and cardiac autonomic neuropathy. While the relationship between the autonomic nervous system and the cytokine cascade in general has been studied extensively, the interplay between the inflammatory response caused by SARS-CoV-2 and autonomic cardiovascular regulation remains largely unclear. We reviewed the current literature on the potential diagnostic and prognostic value of autonomic neurocardiac function assessment via analysis of HRV including time domain and spectral analysis techniques in patients with COVID-19. Furthermore, we discuss potential therapeutic targets of modulating neurocardiac function in this high-risk population including HRV biofeedback and the impact of long COVID on HRV as well as the approaches of clinical management. These topics might be of particular interest with respect to multimodal pandemic preparedness concepts.

Keywords: COVID-19; SARS-CoV-2; autonomic; cardiac; cardiovascular; heart rate variability; parasympathetic; sympathetic.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Decomposing a wave function into simple sinusoidal functions. (A) is a wave function s3 that consists of the sum of two simple sinusoidal functions, s1 (blue) and s2 (yellow) in (B). The complex signal composed of a myriad of frequencies is transformed by a filter into simple waves. Analysis of HRV using frequency domain methods functions in a similar fashion; the oscillation of the HRV is converted into a complex signal (analog to (A)), which then can be decomposed into various frequencies (analog to (B)) so that their individual contribution can be measured.
Figure 2
Figure 2
Possible pathways whereby SARS-CoV-2 might reach neural targets within the autonomic nervous system to cause neurocardiac dysfunction.
Figure 3
Figure 3
HRV Biofeedback training. The drawing shows a subject undergoing HRV biofeedback with continuous measurement of HRV via an ear clip and visualization on the computer screen via a hovering butterfly that rises in response to an increase and descents during a decrease in HRV while the subjects perform a metronomic breathing exercise to increase parasympathetic outflow and thereby HRV.

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. World Health Organization WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. [(accessed on 5 May 2021)]. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
    1. Rahman A., Sathi N.J. Risk factors of the severity of COVID-19: A meta-analysis. Int. J. Clin. Pract. 2020;75:e13916. doi: 10.1111/ijcp.13916. - DOI - PubMed
    1. Oudit G.Y., Kassiri Z., Jiang C., Liu P.P., Poutanen S.M., Penninger J.M., Butany J. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Investig. 2009;39:618–625. doi: 10.1111/j.1365-2362.2009.02153.x. - DOI - PMC - PubMed
    1. Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 2020;14:185–192. doi: 10.1007/s11684-020-0754-0. - DOI - PMC - PubMed

LinkOut - more resources